331 related articles for article (PubMed ID: 18577797)
1. Incidence of metallo beta lactamase producing Pseudomonas aeruginosa in ICU patients.
Varaiya A; Kulkarni N; Kulkarni M; Bhalekar P; Dogra J
Indian J Med Res; 2008 Apr; 127(4):398-402. PubMed ID: 18577797
[TBL] [Abstract][Full Text] [Related]
2. A preliminary study on metallo-beta-lactamase producing Pseudomonas aeruginosa in hospitalized patients.
Navaneeth BV; Sridaran D; Sahay D; Belwadi MR
Indian J Med Res; 2002 Dec; 116():264-7. PubMed ID: 12807154
[TBL] [Abstract][Full Text] [Related]
3. Incidence of metallo-beta-lactamase-producing Pseudomonas aeruginosa in diabetes and cancer patients.
Varaiya A; Kulkarni M; Bhalekar P; Dogra J
Indian J Pathol Microbiol; 2008; 51(2):200-3. PubMed ID: 18603681
[TBL] [Abstract][Full Text] [Related]
4. Detection of metallo betalactamase producing Pseudomonas aeruginosa in hospitalized patients.
Hemalatha V; Sekar U; Kamat V
Indian J Med Res; 2005 Aug; 122(2):148-52. PubMed ID: 16177473
[TBL] [Abstract][Full Text] [Related]
5. Multi-drug resistant Pseudomonas aeruginosa and Acinetobacter baumannii infections among hospitalized patients: risk factors and outcomes.
Shanthi M; Sekar U
J Assoc Physicians India; 2009 Sep; 57():636, 638-40, 645. PubMed ID: 20214000
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of metallo-β-lactamase-producing Pseudomonas aeruginosa isolated from diabetic foot ulcer patients.
Zubair M; Malik A; Ahmad J
Diabetes Metab Syndr; 2011; 5(2):90-2. PubMed ID: 22813410
[TBL] [Abstract][Full Text] [Related]
7. A simple screening test for the detection of metallo-β-lactamase-producing Pseudomonas aeruginosa and Acinetobacter in a tertiary care hospital.
Wan Nor Amilah WA; Noor Izani NJ; Ng WK; Ashraful Haq J
Trop Biomed; 2012 Dec; 29(4):588-97. PubMed ID: 23202604
[TBL] [Abstract][Full Text] [Related]
8. [Metallo-beta-lactamase-mediated resistance among carbapenem-resistant Pseudomonas aeruginosa clinical isolates].
Mereuţă AI; Tuchiluş C; Bădescu AC; Iancu LS
Rev Med Chir Soc Med Nat Iasi; 2011; 115(4):1208-13. PubMed ID: 22276471
[TBL] [Abstract][Full Text] [Related]
9. Dissemination of Pseudomonas aeruginosa producing SPM-1-like and IMP-1-like metallo-beta-lactamases in hospitals from southern Brazil.
Martins AF; Zavascki AP; Gaspareto PB; Barth AL
Infection; 2007 Dec; 35(6):457-60. PubMed ID: 18034208
[TBL] [Abstract][Full Text] [Related]
10. Nosocomial infections with metallo-beta-lactamase-producing Pseudomonas aeruginosa: molecular epidemiology, risk factors, clinical features and outcomes.
Lucena A; Dalla Costa LM; Nogueira KS; Matos AP; Gales AC; Paganini MC; Castro ME; Raboni SM
J Hosp Infect; 2014 Aug; 87(4):234-40. PubMed ID: 25027563
[TBL] [Abstract][Full Text] [Related]
11. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-{beta}-lactamase in a teaching hospital in southern Brazil.
Zavascki AP; Gaspareto PB; Martins AF; Gonçalves AL; Barth AL
J Antimicrob Chemother; 2005 Dec; 56(6):1148-51. PubMed ID: 16239284
[TBL] [Abstract][Full Text] [Related]
12. The laboratory diagnosis of Pseudomonas aeruginosa that produce metallo-β-lactamases in a Dutch tertiary care centre.
van der Bij AK; Mol M; van Westreenen M; Goessens WH; Pitout JD
Scand J Infect Dis; 2011 Aug; 43(8):596-602. PubMed ID: 21506891
[TBL] [Abstract][Full Text] [Related]
13. bla(IMP) and bla(VIM) mediated carbapenem resistance in Pseudomonas and Acinetobacter species in India.
Amudhan MS; Sekar U; Kamalanathan A; Balaraman S
J Infect Dev Ctries; 2012 Nov; 6(11):757-62. PubMed ID: 23277500
[TBL] [Abstract][Full Text] [Related]
14. Nosocomial outbreak by imipenem-resistant metallo-beta-lactamase-producing Pseudomonas aeruginosa in an adult intensive care unit in a Brazilian teaching hospital.
Cezário RC; Duarte De Morais L; Ferreira JC; Costa-Pinto RM; da Costa Darini AL; Gontijo-Filho PP
Enferm Infecc Microbiol Clin; 2009 May; 27(5):269-74. PubMed ID: 19386392
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of metallo-beta-lactamase among Pseudomonas aeruginosa and Acinetobacter baumannii isolated from burn wounds and in vitro activities of antibiotic combinations against these isolates.
Altoparlak U; Aktas F; Celebi D; Ozkurt Z; Akcay MN
Burns; 2005 Sep; 31(6):707-10. PubMed ID: 16129224
[TBL] [Abstract][Full Text] [Related]
16. [Susceptibility to chemotherapeutics and the occurrence of metallo-beta-lactamases in hospital Pseudomonas aeruginosa strains].
Nowak P; Targosz A; Budak A; Oleksiak D; Geza G; Skałkowska M
Med Dosw Mikrobiol; 2006; 58(3):231-7. PubMed ID: 17340998
[TBL] [Abstract][Full Text] [Related]
17. [Antibiotic susceptibility rates and beta-lactam resistance mechanisms of Pseudomonas aeruginosa strains].
Aktaş Z; Satana D; Kayacan C; Can B; Gönüllü N; Küçükbasmacı O
Mikrobiyol Bul; 2012 Jul; 46(3):386-97. PubMed ID: 22951651
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of phenotypic tests for the detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa in a low prevalence country.
Samuelsen O; Buarø L; Giske CG; Simonsen GS; Aasnaes B; Sundsfjord A
J Antimicrob Chemother; 2008 Apr; 61(4):827-30. PubMed ID: 18227087
[TBL] [Abstract][Full Text] [Related]
19. Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase.
Gales AC; Menezes LC; Silbert S; Sader HS
J Antimicrob Chemother; 2003 Oct; 52(4):699-702. PubMed ID: 12951331
[TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem.
Riera E; Cabot G; Mulet X; García-Castillo M; del Campo R; Juan C; Cantón R; Oliver A
J Antimicrob Chemother; 2011 Sep; 66(9):2022-7. PubMed ID: 21653605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
